Skip to main content
Caplight Logo









Avicenna.AI

Avicenna.AI

Private
La CiotatHealthcare & Life Scienceshttps://avicenna.ai

Last Round

Series A

Feb 8, 2023

Total Funding Raised

$10.2M

Company Overview

Avicenna.AI operates in Healthcare & Life Sciences and is based in La Ciotat. Its latest recorded funding round was a Series A round in February 2023.

Avicenna.AI is a healthtech company that develops AI-based solutions for radiology to accelerate therapeutic decision-making and improve patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Avicenna.AI Comparables

Compare Avicenna.AI with similar companies based on industry and business-model similarity.

Avicenna.AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RapidAI
84%
Aidoc
81%
Brainomix
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Avicenna.AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 8, 2023
SeedFeb 6, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Avicenna.AI Investors

Notable investors and investment history

Avicenna.AI investors
InvestorRounds
InnovacomSeed, Series A
Cemag InvestSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 1, 2026

    Monthly visitors grew 79% MoM, reaching 4.1K.

  • Nov 24, 2025

    Expands U.S. access to advanced medical imaging AI technology.

Book a demo to see all signals

For institutional investors. Book with your work email.

Avicenna.AI Filings

Explore SEC and related filing metadata, where available.

Avicenna.AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Avicenna.AI's valuation, stock price, and market status.

Is Avicenna.AI a public or private company?

Avicenna.AI is a private company.

What is the current stock price of Avicenna.AI?

Avicenna.AI is a private company, so its shares have no public market price. Caplight tracks Avicenna.AI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Avicenna.AI worth (valuation)?

Valuation information for Avicenna.AI is not publicly available.

Can I buy Avicenna.AI stock?

Avicenna.AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Avicenna.AI's last funding round?

Avicenna.AI's most recent funding round was Series A on February 8, 2023.

Who are the main investors in Avicenna.AI?

Key investors in Avicenna.AI include Innovacom, Cemag Invest.

Will Avicenna.AI IPO soon?

No public IPO plans have been announced for Avicenna.AI.

How can I track Avicenna.AI secondary market activity?

Caplight tracks bids, offers, and trades in Avicenna.AI's shares on secondary markets.

Firmographic Details

HeadquartersLa Ciotat
Employee Range24
Year Founded2018
Last FundingFeb 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?